DepressionNCT07094243
Motivational Psychotherapy for Adolescent Depression
A study testing Motivational Psychotherapy in people with Depression and Low Academic Self-Concept, run by Atefe Momeni at 1 site in Iran.
Trial summary
This pilot study investigates the effectiveness of Motivational Psychotherapy in reducing symptoms of depression and improving academic self-concept among adolescent girls in Iran. Read more about this study
- Who is it for?
- Ages 13 to 17 years, women only
- Conditions the study is for
- Depression, Low Academic Self-Concept
- What is being tested?
- Motivational Psychotherapy
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 30 participants
- Where
- 1 siteIran
- Study dates
- 5 Nov 2023to 20 Jan 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 13 to 17 years
- Women only
- No healthy volunteers
- Child
Who may be able to join
- Female adolescents aged 13 to 17 years
- Clinical diagnosis of mild to moderate depression based on DSM-5 criteria
- Currently enrolled in middle or high school
- Informed consent obtained from parents/legal guardians and assent from adolescents
Who cannot join
- Severe depression requiring urgent psychiatric care
- Diagnosis of a major psychiatric disorder (e.g., bipolar disorder, psychosis)
- Ongoing psychotherapy or psychotropic medication use
- Significant cognitive or developmental disability interfering with participation
- -
Trial locations and contacts
1 site in 1 country.
Iran1 site
Islamic Azad University, Tehran Electronic Branch
Tehran, Tehran Province, 14398-14994
About this study
Official title: Motivational Psychotherapy for Adolescent Depression and Academic Self-Concept: A Pilot Trial in a Non-Western Context
This pilot study investigates the effectiveness of Motivational Psychotherapy in reducing symptoms of depression and improving academic self-concept among adolescent girls in Iran. A total of 30 participants aged 13 to 17 were randomly assigned to an experimental group receiving Motivational Psychotherapy and a control group receiving no treatment. The intervention consisted of 8 weekly sessions based on the principles of motivational interviewing and was tailored to adolescent needs. Outcomes were measured using the Beck Depression Inventory-II (BDI-II) and the Academic Self-Concept Questionnaire (ASCQ). Results suggest the potential benefit of this culturally sensitive approach in non-Western adolescent populations.
Read the detailed description
This randomized controlled pilot trial evaluated the effectiveness of Motivational Psychotherapy in reducing depressive symptoms and improving academic self-concept among adolescent girls in Iran. A total of 30 participants aged 13-17 years were randomly assigned to either the Motivational Psychotherapy group or a no-intervention control group.
The intervention consisted of 8 weekly individual sessions (60 minutes each) based on a manualized Motivational Psychotherapy protocol, adapted for adolescents in a non-Western context. The sessions focused on resolving ambivalence, enhancing intrinsic motivation, and strengthening environmental support.
Outcome measures included the Beck Depression Inventory-II (BDI-II) for depressive symptoms and the Academic Self-Concept Questionnaire (ASCQ) for academic self-concept. Data were analyzed using ANCOVA to control for baseline differences between groups. The results showed significant improvement in depression scores and academic self-concept in the intervention group compared to the control group, supporting the feasibility and cultural relevance of Motivational Psychotherapy for adolescent mental health.
- Conditions
- Depression, Low Academic Self-Concept
- Being tested
- Motivational Psychotherapy
- Keywords
- Adolescent mental health, Motivational psychotherapy, Motivational interviewing, Academic self-concept, Pilot trial, Non-Western context
- Medical subject headings
- Depression
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Motivational PsychotherapyBehavioural
A structured short-term intervention based on motivational psychotherapy, delivered in individual sessions over 8 weeks to improve adolescent depression and academic self-concept.
| Study group | Role | What they receive |
|---|---|---|
| Motivational Psychotherapy | Experimental | Participants receive Motivational Psychotherapy intervention. Receives: Behavioral: Motivational Psychotherapy |
| No Intervention | No intervention | Participants receive no psychological intervention during the study period. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in Depression Score from Baseline to 8 Weeks Post-Intervention
Depression symptoms will be assessed using the Beck Depression Inventory-II (BDI-II; range 0-63, higher scores indicate worse depression). The mean change in BDI-II scores from baseline to 8 weeks will be analyzed between the Motivational Psychotherapy and control groups.
Measured: Baseline and 8 weeks after start of intervention
Secondary outcomes (1)
Change in Depression Score from Baseline to 8 Weeks Post-Intervention
Depression symptoms will be assessed using the Beck Depression Inventory-II (BDI-II). The primary outcome is the mean change in BDI-II scores from baseline to 8 weeks after the intervention. The comparison will be made between the experimental group (receiving motivational psychotherapy) and the control group.
Measured: Baseline and 8 weeks after start of intervention
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted30 Jul 2025
- Study start5 Nov 2023
- Primary completion20 Jan 2024
- Study completion20 Jan 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for DepressionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Model description
- Two parallel groups: a motivational psychotherapy group and a control group (no intervention).
- Masking
- None (open label)
- Enrolment
- 30 participants (actual)
Sponsor and investigators
- Lead sponsor
- Atefe Momeni
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor-investigator, Atefe Momeni, Islamic Azad University, Sanandaj
- Investigators
- Hossein Sahebdel, Associate Professor of Counsel, Principal investigator, Islamic Azad University, Tehran Electronic Branch
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07094243
- Sponsor's protocol ID
- Momeni2025-MP
- Status last verified
- Jul 2025
- First submitted
- 23 Jul 2025
- Last updated
- 31 Jul 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 31 Jul 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Motivational Psychotherapy for Adolescent Depression and Academic Self-Concept: A Pilot Trial in a Non-Western Context
- ClinicalTrials.gov ID
- NCT07094243
- Acronym / sponsor ID
- Momeni2025-MP
- Conditions
- Depression, Low Academic Self-Concept
- Keywords
- Adolescent mental health, Motivational psychotherapy, Motivational interviewing, Academic self-concept, Pilot trial, Non-Western context
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 30 participants (actual)
- Lead sponsor
- Atefe MomeniUniversity, hospital or other
- Study start
- 5 Nov 2023 (actual)
- Primary completion
- 20 Jan 2024 (actual)
- Study completion
- 20 Jan 2024 (actual)
- First posted
- 30 Jul 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This pilot study investigates the effectiveness of Motivational Psychotherapy in reducing symptoms of depression and improving academic self-concept among adolescent girls in Iran. A total of 30 participants aged 13 to 17 were randomly assigned to an experimental group receiving Motivational Psychotherapy and a control group receiving no treatment. The intervention consisted of 8 weekly sessions based on the principles of motivational interviewing and was tailored to adolescent needs. Outcomes were measured using the Beck Depression Inventory-II (BDI-II) and the Academic Self-Concept Questionnaire (ASCQ). Results suggest the potential benefit of this culturally sensitive approach in non-Western adolescent populations.
Detailed description
This randomized controlled pilot trial evaluated the effectiveness of Motivational Psychotherapy in reducing depressive symptoms and improving academic self-concept among adolescent girls in Iran. A total of 30 participants aged 13-17 years were randomly assigned to either the Motivational Psychotherapy group or a no-intervention control group.
The intervention consisted of 8 weekly individual sessions (60 minutes each) based on a manualized Motivational Psychotherapy protocol, adapted for adolescents in a non-Western context. The sessions focused on resolving ambivalence, enhancing intrinsic motivation, and strengthening environmental support.
Outcome measures included the Beck Depression Inventory-II (BDI-II) for depressive symptoms and the Academic Self-Concept Questionnaire (ASCQ) for academic self-concept. Data were analyzed using ANCOVA to control for baseline differences between groups. The results showed significant improvement in depression scores and academic self-concept in the intervention group compared to the control group, supporting the feasibility and cultural relevance of Motivational Psychotherapy for adolescent mental health.
Study design
- Primary purpose
- Treatment
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- Two parallel groups: a motivational psychotherapy group and a control group (no intervention).
| Arm | Type | Receives |
|---|---|---|
| Motivational Psychotherapy | Experimental | Behavioral: Motivational PsychotherapyParticipants receive Motivational Psychotherapy intervention. |
| No Intervention | No intervention | –Participants receive no psychological intervention during the study period. |
Who may qualify
- Ages
- 13 to 17 years
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Child
Key inclusion criteria (4 listed)
- Female adolescents aged 13 to 17 years
- Clinical diagnosis of mild to moderate depression based on DSM-5 criteria
- Currently enrolled in middle or high school
- Informed consent obtained from parents/legal guardians and assent from adolescents
Key exclusion criteria (5 listed)
- Severe depression requiring urgent psychiatric care
- Diagnosis of a major psychiatric disorder (e.g., bipolar disorder, psychosis)
- Ongoing psychotherapy or psychotropic medication use
- Significant cognitive or developmental disability interfering with participation
- -
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Motivational PsychotherapyA structured short-term intervention based on motivational psychotherapy, delivered in individual sessions over 8 weeks to improve adolescent depression and academic self-concept. | Behavioural | Motivational Psychotherapy |
Primary outcome
Change in Depression Score from Baseline to 8 Weeks Post-Intervention
Time frame: Baseline and 8 weeks after start of intervention
Depression symptoms will be assessed using the Beck Depression Inventory-II (BDI-II; range 0-63, higher scores indicate worse depression). The mean change in BDI-II scores from baseline to 8 weeks will be analyzed between the Motivational Psychotherapy and control groups.
1 secondary outcome
Change in Depression Score from Baseline to 8 Weeks Post-Intervention
Time frame: Baseline and 8 weeks after start of intervention
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 31 Jul 2025.
- Effectiveness of Motivational Psychotherapy in Adolescent DepressionLink provided by the sponsor.
- Individual participant dataSharing planned: No
Related trials for Depression
Not yet recruiting
Mandala Coloring in Late Pregnancy
Pregnancy, Anxiety
Not yet recruitingObservational study
Ecological Momentary Assessment of State-Dependent Decision-Making and Metacognition Across a Psychopathology Continuum
Depression, Anxiety
Not yet recruiting
Adapting the ESTEEM Intervention to Improve Mental Health and PrEP Uptake Among Men at Risk of HIV
PrEP Use
Recruiting
Cancer Pain Management Using a Web-based Intervention
Cancer of Breast, Depressive Symptoms
Active, not recruiting
Improving Student Mental Health Through a Universal Trauma-Informed Intervention
Anxiety Symptoms, Post-traumatic Stress Symptoms
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Hossein Sahebdel, Associate Professor of Counsel principal investigator
Islamic Azad University, Tehran Electronic Branch
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Motivational Psychotherapy in people with Depression and Low Academic Self-Concept, run by Atefe Momeni at 1 site in Iran.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 31 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Iran. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in Depression Score from Baseline to 8 Weeks Post-Intervention (time frame: Baseline and 8 weeks after start of intervention). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Jul 2025.